NeuroBo Pharmaceuticals, Inc. - Common Stock (NRBO)

2.3600
0.00 (0.00%)

Neurobo Pharmaceuticals is a biotechnology company focused on developing innovative therapies for neurodegenerative diseases and other severe conditions

Through its cutting-edge research and development efforts, the company aims to create transformative treatments that address significant unmet medical needs in areas such as cognition, memory, and overall brain health. By harnessing advanced technology and scientific insights, Neurobo strives to improve patient outcomes and enhance the quality of life for individuals affected by debilitating neurological disorders.

SummaryNewsPress ReleasesChartHistoricalFAQ
Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing
NEW YORK, NY / ACCESSWIRE / December 3, 2024 / Investor Summit Group, committed to advancing the MicroCap and SmallCap investment community, announces that the November 21, 2024 Winter Investor Summit Virtual Conference presentations are now available for on-demand viewing.
Via ACCESSWIRE · December 3, 2024
Life Sciences Investor Forum: Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
By Virtual Investor Conferences · Via GlobeNewswire · November 15, 2024
Life Sciences Investor Forum Agenda Announced for November 14th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
By Virtual Investor Conferences · Via GlobeNewswire · November 12, 2024
NeuroBo Pharmaceuticals to Present at the November 21st Virtual Investor Summit Microcap Event
CAMBRIDGE, MA / ACCESSWIRE / November 11, 2024 / NeuroBo Pharmaceuticals, Inc. (NASDAQNRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that Hyung Heon Kim, President and Chief Executive Officer and Marshall H. Woodworth, Chief Financial Officer, will present a company overview at the Q4 Investor Summit. The company will be available for 1-on-1 meetings throughout the day in addition to its presentation.
Via ACCESSWIRE · November 11, 2024
NeuroBo Pharmaceuticals Inc. (NASDAQ: NRBO) is One of Thursday Morning’s Most Active Stocks
NeuroBo Pharmaceuticals, Inc. (NASDAQNRBO) is one today’s most active stocks by volume. So far today, approximately 36,413 shares of NeuroBo Pharmaceuticals, Inc. have been exchanged, as compared to an average 30-day volume of 47,156 shares.
Via Investor Brand Network · February 1, 2024
Life Science Investor Forum: Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
By Virtual Investor Conferences · Via GlobeNewswire · December 15, 2023
Life Science Investor Forum Agenda Announced for December 14th, 2023
NEW YORK, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the Life Science Investor Forum to be held December 14th. This event is sponsored by Zacks Small-Cap Research. Individual investors, institutional investors, advisors, and analysts are invited to attend.
By Virtual Investor Conferences · Via GlobeNewswire · December 12, 2023
The Center for Advancing Innovation's Board Member, Gil Price, Realizes Turn Around in Less than 12 Months
The Center for Advancing Innovation’s Board Member, Gil Price, Realizes Turn Around in Less than 12 Months - IssueWire
Via IssueWire · November 15, 2022
Biotechs with Evolving Therapies Have Potential to Revolutionize Treatments for Pancreatic Cancer
EQNX::TICKER_START (NASDAQONCY),(TSX:ONC),NASDAQ:MACKNASDAQMACK)(NASDAQ:NRBONASDAQNRBO,(NYSE:MRKNYSE),(NASDAQ:RNAZRNAZ), EQNX::TICKER_END
Via FinancialNewsMedia · November 10, 2022
Accelerating R&D Activities in Breast Cancer Therapy Market Fueling Optimism for Development of Advanced Treatments
Palm Beach, FL – October 14, 2021 – FinancialNewsMedia.com News Commentary – The breast cancer drugs market, which has been steadily growing over the past few years, is projected to continue this trend for the next several years. The breast cancer drugs market consists of sales of breast cancer drugs and related services. This industry […]
Via FinancialNewsMedia · October 14, 2021